London, UK (PRWEB) July 16, 2015
Market Publishers Ltd announces that topical life sciences market research studies elaborated by GlobalData have been recently added to its catalogue.
PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023. The 2013 sales for melanoma stood at around USD 1.34 billion across the 8 MM discussed in the study. The market is poised to increase by fourfold (at 15.5% CAGR) in the offing, reaching a value of USD 5.64 billion by 2023. The growth is set to be driven by a hike in incident cases of melanoma and also the approval and uptake of premium-priced products. The report provides a detailed analysis of the worldwide melanoma therapeutics market, analysing key trends, innovative technologies and products, market segments, and companies likely to impact the market in the offing. A comprehensive pipeline analysis is available.
Artificial Pancreas - Pipeline Review, 2015. The study provides an in-depth overview of artificial pancreas presently in pipeline stage. It gives comprehensive information on the pipeline products with a comparative analysis of the products under development – ranging from early development until approval. The report presents an overview of the dominant players involved in the development of novel pipeline products. It also provides details about clinical studies in progress, which comprises trial stage, trial status, the start and end dates of trials, and the number of trials for the leading artificial pancreas pipeline products. Recent developments in the industry are also described.
Arthroscopy - Pipeline Review, 2015. The research publication provides an insightful overview of arthroscopy products which are currently in pipeline. It offers details of key pipeline products, including product description, collaboration and licensing details and other development activities; examines the leading players engaged in the development of arthroscopy products alongside listing all their pipeline projects; covers pipeline products by stage of development, by segment, by territory, by regulatory path, estimated approval date; provides key clinical studies data of on-going trials specific to pipeline products; sheds light on recent industry developments.
Intravascular Ultrasound Systems (IVUS) - Pipeline Review, 2015. The study presents comprehensive coverage of the IVUS products in pipeline, based on development stage, segment, regulatory path, territory, and the estimated date of approval. The study offers a detailed discussion of the major players involved in the development of IVUS and lists their key products in pipeline; canvasses the recent industry developments and trends. Arbor Ultrasound Technologies, LLC, Medtronic plc, Georgia Institute of Technology, SIBUS Medical, Inc., University of Texas at Austin, University of Oxford, and Volcano Corporation are the leading players.
More studies by the publisher can be found at GlobalData page.